NSE:COHANCE

Cohance Lifesciences Stock Forecast

etoro logo Buy COHANCE
*Your capital is at risk
₹463.95
+16.95 (+3.79%)
At Close: Aug 11, 2026

Should you buy COHANCE.NS stock?

Last updated:

Based on market data through , StockInvest.us rates Cohance Lifesciences Limited (COHANCE.NS) as Hold/Accumulate with a technical score of 0.73 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.

  • Hold signal since
  • Price since signal Up 3.79%
  • 3-month trend forecast Up 1.08%
  • Hold/Accumulate 0.73
AI Analysis AI Analysis of COHANCE.NS AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add COHANCE to Watchlist?
Some Reasons Why To Add COHANCE:
  • Low bankruptcy risk (Altman Z-Score: 9.69)
  • Lower volatility than the market (beta 0.60)
  • Solid financial health (Piotroski 6/9)
PDF

Green day on Tuesday for Cohance Lifesciences Limited
(Market data through Aug 11, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Aug 10, 2026 Gain 3.79%

The Cohance Lifesciences Limited stock price gained 3.79% on the last trading day (Tuesday, 11th Aug 2026), rising from ₹447.00 to ₹463.95. It has now gained 5 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.54% from a day low at ₹445.55 to a day high of ₹474.70. The price has risen in 7 of the last 10 days and is up by 8.97% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 900 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately ₹1.05 billion.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Cohance Lifesciences Limited stock with a 90% probability to be traded between ₹412.58 and ₹495.13 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

COHANCE.NS Signals & Forecast

The Cohance Lifesciences Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at ₹439.33 and ₹441.49. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 22, 2026, and so far it has risen 14.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Cohance Lifesciences Limited stock

Cohance Lifesciences Limited finds support from accumulated volume at ₹457.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved ₹29.15 (6.54%) between high and low. For the last week, the stock has had daily average volatility of 5.42%.

Our recommended stop-loss: ₹446.78 (-3.70%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 35 days ago.)

Trading Expectations (COHANCE.NS) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Cohance Lifesciences Limited to open at ₹461.40, and during the day (based on 14 day Average True Range), to move between ₹455.15 and ₹472.75, which gives a possible trading interval of +/-₹17.61 (+/-3.87%) up or down from last closing price. If Cohance Lifesciences Limited takes out the full calculated possible swing range there will be an estimated 3.87% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at ₹457.80 (1.33%) than the resistance at ₹484.65 (4.46%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cohance Lifesciences Limited stock A Buy?

Cohance Lifesciences Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.725 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - ₹461.40 ( 0.550%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

COHANCE.NS Performance

Trading levels for COHANCE.NS

StockInvest.us
Full Access. No Commitment. Up to 14 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 490.55 5.73%
R2 479.41 3.33%
R1 472.54 1.85%
Price 463.95
S1 450.26 -2.95%
S2 443.39 -4.43%
S3 432.25 -6.83%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 484.65 4.46%
Price 463.95
S1 457.80 -1.33%
S2 438.90 -5.40%
S3 428.35 -7.67%

COHANCE Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Sep 09, 2022 Sep 09, 2022 Oct 02, 2022 ₹5.00 0%
2 May 13, 2022 May 13, 2022 Jun 08, 2022 ₹1.00 0%
3 Feb 15, 2022 Feb 15, 2022 Mar 10, 2022 ₹2.00 0%
4 Aug 13, 2021 Aug 13, 2021 Sep 30, 2021 ₹1.00 0%
5 Feb 17, 2021 Feb 17, 2021 Mar 11, 2021 ₹1.00 0%

FAQ

What is the symbol for Cohance Lifesciences Limited Stock and on which exchange is it traded?
The symbol for Cohance Lifesciences Limited is COHANCE.NS and it is traded on the NSE (National Stock Exchange of India).

Should I buy or sell Cohance Lifesciences Limited Stock?
Based on market data through Aug 11, 2026, StockInvest.us rates Cohance Lifesciences Limited (COHANCE.NS) as Hold/Accumulate with a technical score of 0.73 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Aug 10, 2026, the price has risen 3.79%. The current 3-month trend forecast projects a rise of 1.08%.

How to buy Cohance Lifesciences Limited Stock?
Cohance Lifesciences Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cohance Lifesciences Limited Stock.

What's the current price of Cohance Lifesciences Limited Stock?
As of the end of day on the Aug 11, 2026, the price of an Cohance Lifesciences Limited (COHANCE.NS) share was ₹463.95.

What is the 52-week high and low for Cohance Lifesciences Limited Stock?
The 52-week high for Cohance Lifesciences Limited Stock is ₹1,038.90 and the 52-week low is ₹266.70.

What is the market capitalization of Cohance Lifesciences Limited Stock?
As of the Aug 11, 2026, the market capitalization of Cohance Lifesciences Limited is 177.492B.

When is the next earnings date for Cohance Lifesciences Limited?
The upcoming earnings date for Cohance Lifesciences Limited is Nov 02, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE